ART4 and cryohydrocytosis: These results implied that the change in the serum level of glycoprotein LecT-Hepa could predict the antiviral treatment response more quickly than FIB-4 and APRI, even at the first 12 weeks of therapy, which may provide more precise information for treatment protocols of CHC.